KURA
Kura Oncology Inc
NASDAQ: KURA · HEALTHCARE · BIOTECHNOLOGY
$8.83
+0.91% today
Updated 2026-04-30
Market cap
$776.67M
P/E ratio
—
P/S ratio
11.51x
EPS (TTM)
$-3.18
Dividend yield
—
52W range
$5 – $12
Volume
1.5M
Kura Oncology Inc (KURA) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-497.60%
ROE
-94.80%
ROA
-25.30%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2008 | — | $-33623.00 | — | — | — |
| 2009 | — | $-19996.00 | — | — | — |
| 2010 | — | $-22395.00 | — | — | — |
| 2011 | — | $-22395.00 | — | — | — |
| 2012 | — | $-27040.00 | — | — | — |
| 2013 | — | $-27315.00 | — | — | — |
| 2014 | $0.00 | $-11.01M | — | — | — |
| 2015 | $0.00 | $-22.63M | — | — | — |
| 2016 | $0.00 | $-27.56M | — | — | — |
| 2017 | $0.00 | $-35.43M | — | — | — |
| 2018 | $0.00 | $-60.45M | — | — | — |
| 2019 | $0.00 | $-63.14M | — | — | — |
| 2020 | $0.00 | $-89.63M | — | — | — |
| 2021 | $0.00 | $-130.47M | — | — | — |
| 2022 | $0.00 | $-135.84M | — | — | — |
| 2023 | $0.00 | $-152.63M | — | — | — |
| 2024 | $53.88M | $-173.98M | 100.00% | -358.55% | -322.89% |
| 2025 | $67.48M | $-278.67M | 99.92% | -449.94% | -412.95% |